SNT
Click for more information
9.09% 2.4¢ syntara limited

Ann: PXS Company Restructure Sale of Mannitol Business, page-8

  1. primaus72
    3,242 Posts.
    lightbulb Created with Sketch. 97
    clock Created with Sketch.
    03/10/23
    14:46
    Post #: 70149216
    and to think they have raised many hundreds of millions of $ to get a drug thru to ph3 approval then only to find out there is hardly any market for it.

    This biotech game is a hard nut to crack - also doesn’t help when mgt is looking only out for themselves and/or clueless how to generate shareholder wealth
    PXS Price at posting: 3.7¢ Sentiment: Sell Disclosure: Not Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
NEWS Microcap Wrap: 5 explorers with news out today
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
2.4¢ 		Change
0.002(9.09%) 		Mkt cap ! $28.65M
Open High Low Value Volume
2.2¢ 2.5¢ 2.2¢ $12.04K 509.9K

Buyers (Bids)

No. Vol. Price($)
1 82668 2.3¢
 

Sellers (Offers)

Price($) Vol. No.
2.4¢ 100000 1
View Market Depth
Last trade - 15.57pm 28/06/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.